Ultragenyx Shares Target Raised, Maintains Buy Rating on Positive Outcome
Friday, 31 May 2024, 13:59
Ultragenyx Shares Target Raised
The recent performance of Ultragenyx has led to an increase in the target price by analysts, underscoring positive expectations for the company's future.
Maintains Buy Rating on Successful Outcome
The Buy rating has been reaffirmed based on the successful outcome achieved by Ultragenyx, aligning with market optimism.
- Analysts raise target price
- Buy rating maintained
- Positive outcome impact
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.